Methemoglobinemia type 4
MONDO:0009605Any methemoglobinemia in which the cause of the disease is a mutation in the CYB5A gene.
Also known as: CYB5A methemoglobinemia, methemoglobinemia caused by mutation in CYB5A, methemoglobinemia type 4, METAG, isolated 17,20-lyase deficiency, Pure, methemoglobinemia and ambiguous genitalia, methemoglobinemia due to deficiency of cytochrome B5, methemoglobinemia due to deficiency of cytochrome B5, formerly
20 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New blood treatment could block zika in transfusions
Disease control OngoingThis study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe…
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New cord blood matching method could expand transplant access for blood cancer patients
Disease control OngoingThis study tests a new approach to stem cell transplants for people with blood cancers like leukemia and lymphoma. Patients receive a combination of umbilical cord blood and stem cells from a family member, with the cord blood chosen based on specific genetic markers rather than …
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 26, 2026 13:02 UTC